As you know it has been many months since we have heard anything about either of those 2 agreements.. The latest acquisition though, being immediate, does put a slightly different slant on things, positively I mean,. Personally I have put China on hold and do not expect much in the way of any agreements, that bubble burst long ago IMO.. Lets hope I'm wrong!
One would expect the financial benefits to be evident in the next HY report, based on the figured supplied by the company in the acquisition ann.. Additionally, FOD reiterates top line growth of approximately 25% for FY20 and provides revenue guidance of at least $40 million with margins expected to be superior to FY19. The other thing to note is that FOD know has a customer base it may previously not have had exposure to and will no doubt leverage of that for expansion.. Have they factored in organic growth through their acquisition, I don't believe so, if that is the case then the 40 mill revenue forecast I suspect is conservative and we may be in for a sweet surprise..
GLTA
- Forums
- ASX - By Stock
- OJC
- Ann: FOD ACQUIRES ICONIC AUSTRALIAN BRAND
Ann: FOD ACQUIRES ICONIC AUSTRALIAN BRAND, page-39
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OJC (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.40M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $13.05K | 81.61K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35026 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 99988 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 35026 | 0.160 |
1 | 4000 | 0.155 |
1 | 16117 | 0.150 |
1 | 610 | 0.100 |
1 | 5500 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 99988 | 1 |
0.170 | 98497 | 5 |
0.175 | 469522 | 9 |
0.180 | 82530 | 5 |
0.185 | 29834 | 2 |
Last trade - 15.39pm 15/07/2024 (20 minute delay) ? |
Featured News
OJC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online